Evidence map›Paper›PMID 36935719›Full record

ArticleFrontiers in public health2023

Undiagnosed diseases: Needs and opportunities in 20 countries participating in the Undiagnosed Diseases Network International.

Domenica Taruscio, Marco Salvatore, Aimè Lumaka, Claudio Carta, Laura L Cellai, Gianluca Ferrari, Savino Sciascia, Stephen Groft, Yasemin Alanay, Maleeha Azam and 22 more

Registry-linked trialOpen access · goldFull text read
In one paragraph

Article in Frontiers in public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02450851 (Clinical and Genetic Evaluation of Patients With Undiagnosed Disorders Through the Undiagnosed Diseases Network), which is not on this map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
6.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02450851 recruitingnot on this map

Clinical and Genetic Evaluation of Patients With Undiagnosed Disorders Through the Undiagnosed Diseases Network

TypeobservationalSponsorNational Human Genome Research Institute (NHGRI)Ran2015 to 2028Enrolled20,000ConditionsGenetic Disease
3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Covering medical care costs for participants in the eMERGE Network: Challenges for equity and implementation.Genetics in medicine : official journal of the American College of Medical Genetics · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 20 institutions in 19 countries.

Domenica TaruscioNational Centre for Rare Diseases, Istituto Superiore di Sanità, Rome, Italy.
Marco SalvatoreNational Centre for Rare Diseases, Istituto Superiore di Sanità, Rome, Italy.
Aimè LumakaReference Center for Rare and Undiagnosed Diseases, University of Kinshasa, Kinshasa, Democratic Republic of Congo.
Claudio CartaNational Centre for Rare Diseases, Istituto Superiore di Sanità, Rome, Italy.
Laura L CellaiNational Centre for Rare Diseases, Istituto Superiore di Sanità, Rome, Italy.
Gianluca FerrariNational Centre for Rare Diseases, Istituto Superiore di Sanità, Rome, Italy.
Savino SciasciaCenter of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-Net, ERN-Reconnect and RITA-ERN Member) With Nephrology and Dialysis Unit, San Giovanni Bosco Hub Hospital, University of Turin, Turin, Italy.
Stephen GroftNational Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, United States.
Yasemin AlanayACURARE-Rare and Undiagnosed Diseases Center, Acibadem University, Istanbul, Turkey.
Maleeha AzamCOMSATS University Islamabad, Islamabad, Pakistan.
Gareth BaynamRare Care, Clinical Centre of Expertise for Rare and Undiagnosed Diseases, Perth Children's Hospital, Perth, WA, Australia.
Helene CederrothWilhelm Foundation, Stockholm, Sweden.
Eva Maria Cutiongco-de la PazInstitute of Human Genetics, National Institutes of Health, University of the Philippines Manila, Manila, Philippines.
Vajira Harshadeva Weerabaddana DissanayakeDepartment of Anatomy, Genetics and Biomedical Informatics, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka.
Roberto GiuglianiHouse of Rares, Medical Genetics Service, HCPA, Department Genetics UFRGS and DASA, Porto Alegre, Brazil.
Claudia Gonzaga-JaureguiInternational Laboratory for Human Genome Research, Universidad Nacional Autonoma de Mexico, Juriquilla, Queretaro, Mexico.
Dineshani HettiarachchiDepartment of Anatomy, Genetics and Biomedical Informatics, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka.
Oleg KvlividzeGeorgian Foundation for Genetic and Rare Diseases (GeRaD), School of Medicine, New Vision University, Tbilisi, Georgia.
Guida LandoureFaculté de Médecine et d'Odontostomatologie, l'Université des Sciences, des Techniques et des Technologies de Bamako, Bamako, Mali.
Prince MakayReference Center for Rare and Undiagnosed Diseases, University of Kinshasa, Kinshasa, Democratic Republic of Congo.
Béla MeleghDepartment of Medical Genetics, School of Medicine, University of Pécs, Pécs, Hungary.
Ugur OzbekACURARE-Rare and Undiagnosed Diseases Center, Acibadem University, Istanbul, Turkey.
Ratna Dua PuriInstitute of Medical Genetics and Genomics, Sir Ganga Ram Hospital, New Delhi, India.
Vanessa RomeroSchool of Medicine, Universidad San Francisco de Quito, Quito, Ecuador.
Vinod ScariaCSIR Institute of Genomics and Integrative Biology, New Delhi, India.
Saumya S JamuarSinghealth Duke-NUS Genomic Medicine Centre, KK Women's and Children's Hospital, Singapore, Singapore.
Vorasuk ShotelersukCenter of Excellence for Medical Genomics, Department of Pediatrics, Faculty of Medicine, King Chulalongkorn Memorial Hospital and Chulalongkorn University, Bangkok, Thailand.
Dario RoccatelloCenter of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-Net, ERN-Reconnect and RITA-ERN Member) With Nephrology and Dialysis Unit, San Giovanni Bosco Hub Hospital, University of Turin, Turin, Italy.
William A GahlNational Institutes of Health, National Human Genome Research Institute, Bethesda, MD, United States.
Samuel A WiafeRare Disease Ghana Initiative, Accra, Ghana.
Olaf BodamerDivision of Genetics and Genomics, Harvard Medical School, Boston Children's Hospital, Boston, MA, United States.
Manuel PosadaRare Diseases Research Institute (IIER), SpainUDP, Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Istituto Superiore di Sanità · ITAcıbadem University · TRUniversity of Colombo · LKUniversity of Kinshasa · CDCOMSATS University Islamabad · PKDuke-NUS Medical School · SGGhana Health Service · GHHarvard University · USInstitute of Genomics and Integrative Biology · INInstituto de Salud Carlos III · ESKing Chulalongkorn Memorial Hospital · THNational Center for Advancing Translational Sciences · USNational Human Genome Research Institute · USOspedale San Giovanni Bosco · ITPrincess Margaret Hospital for Children · AUSir Ganga Ram Hospital · INUniversidade Federal do Rio Grande do Sul · BRUniversidad Nacional Autónoma de México · MXUniversidad San Francisco de Quito · ECUniversité des Sciences, des Techniques et des Technologies de Bamako · ML

Funding

Human Biochemical GeneticsZIAHG000215 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI GAHL, WILLIAM · 2009 to 2025
$72.6M
Undiagnosed Diseases ProgramZIAHG200421 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI GAHL, WILLIAM · 2023 to 2025
$825k
6 · The paper itself

Abstract

Introduction: Rare diseases (RD) are a health priority worldwide, overall affecting hundreds of millions of people globally. Early and accurate diagnosis is essential to support clinical care but remains challenging in many countries, especially the low- and medium-income ones. Hence, undiagnosed RD (URD) account for a significant portion of the overall RD burden. Methods: In October 2020, the Developing Nations Working Group of the Undiagnosed Diseases Network International (DNWG-UDNI) launched a survey among its members, belonging to 20 countries across all continents, to map unmet needs and opportunities for patients with URD. The survey was based on questions with open answers and included eight different domains. Conflicting interpretations were resolved in contact with the partners involved. Results: All members responded to the survey. The results indicated that the scientific and medical centers make substantial efforts to respond to the unmet needs of patients. In most countries, there is a high awareness of RD issues. Scarcity of resources was highlighted as a major problem, leading to reduced availability of diagnostic expertise and research. Serious equity in accessibility to services were highlighted both within and between participating countries. Regulatory problems, including securing informed consent, difficulties in sending DNA to foreign laboratories, protection of intellectual property, and conflicts of interest on the part of service providers, remain issues of concern. Finally, most respondents stressed the need to strengthen international cooperation in terms of data sharing, clinical research, and diagnostic expertise for URD patients in low and medium income countries. Discussion: The survey highlighted that many countries experienced a discrepancy between the growing expertise and scientific value, the level of awareness and commitment on the part of relevant parties, and funding bodies. Country-tailored public health actions, including general syllabus of medical schools and of the education of other health professionals, are needed to reduce such gaps.

Indexed as

Undiagnosed DiseasesHumansRare DiseasesSurveys and Questionnairesdata sharingdeveloping nationsrare diseasessurveyUndiagnosed Diseases

Identifiers

PMID36935719
PMCPMC10017550
OpenAlexW4322773081

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read17
identifiers read1
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.